Immunoscintigraphy is a nuclear medicine procedure used to find cancer cells in the body by injecting a radioactively labeled antibody, which binds predominantly to cancer cells and then scanning for concentrations of radioactive emissions.
[1][2] Immunoscintigraphy is performed using a variety of radiopharmaceuticals, for a large range of purposes.
Colorectal cancer is one of the most studied areas, with indium-111 or technetium-99m labelled epitopes of the carcinoembryonic antigen.
[3] The antibody capromab pendetide reacts with prostate membrane specific antigen (PMSA) and can be labelled with 111In.
You can help Wikipedia by expanding it.This nuclear medicine article is a stub.